Bookmark
Forward
A woman with a progressive skin tumor during immunotherapy].
Yorick Sandberg, Reinier Sprenger, Michael A den Bakker
Nederlands tijdschrift voor geneeskunde 2020 Mar 19
Sizes of these terms reflect their relevance to your search.
A 62-year-old woman who was treated with daratumumab, bortezomib and dexamethasone for multiple myeloma, developed a skin tumor on her back. Histologic examination of a biopsy from the nodule revealed cutaneous plasmacytoma. Secondary plasmacytoma is an indicator of poor prognosis.
Citation
Yorick Sandberg, Reinier Sprenger, Michael A den Bakker.
A woman with a progressive skin tumor during immunotherapy].
Nederlands tijdschrift voor geneeskunde.
2020 Mar 19;164
Mesh Tags
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Biopsy
Bortezomib
Dexamethasone
Female
Humans
Immunologic Factors
Immunotherapy
Middle Aged
Multiple Myeloma
Plasmacytoma
Prognosis
Skin Neoplasms
Substances
Antibodies, Monoclonal
Immunologic Factors
daratumumab
Bortezomib
Dexamethasone
PMID: 32391990
View Full Text